viewTHC Global Group Ltd

Full interview: THC Global receives final licences and will complete product validation by end of year

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive on receiving the final licences required for Australian production and distribution of narcotic medicines, including medicinal cannabis, for the recently opened Southport and Bundaberg manufacturing facilities in Queensland.

The company will also complete product validation by the end of 2019 and expects to be supplying medicinal cannabis to Australian patients early in 2020.

In addition, the CEO updated the market about an increased presence for THC Global in New Zealand.

Quick facts: THC Global Group Ltd

Price: - AUD

Market: ASX
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...


Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

on 29/1/20

2 min read